Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Indu

Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032

The home infusion therapy market is slated to grow at a substantial rate over 2032, owing to the rising number of outpatient visits. In addition, increasing preference for at-home treatment or post-surgery treatment are also accelerating the use of home infusion therapy devices. Patients that require long-term treatment mostly choose at-home therapy options.

A wide variety of home infusion therapies are available to treat different chronic illnesses. Specialty infusions are administered to patients with hemophilia, arthritis, congestive heart failure, Crohn’s disease, multiple sclerosis (MS), high-risk pregnancy, and several immune deficiencies.

Rising prevalence of hormone disorders and rare diseases has fueled the need for drug therapies involving the administration of antibiotics, total parenteral nutrition (TPN), intravenous immunoglobulin (IVIG), and antivirals. To cope with side effects such as dehydration or soreness associated with intense treatments, physicians recommend home infusion therapy for pain management.

Technological advancements have enabled the development of next-generation smart infusion pumps as a part of clinical decision-support tools to ensure an accurate medication administration process. The advent of smart infusion pumps has enhanced accuracy and KVO with alarms, pressure control systems, and other smart features.

Leveraging recent healthcare trends such as smart diagnosis and treatment, telemedicine, and telehealth, various industry players are introducing novel home infusion devices. For instance, in August 2022, Baxter International Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new syringe infusion pump (SYR) called Novum IQ. With the Dose IQ Software and IQ Enterprise connectivity suite, SYR can effectively integrate with electronic medical records.

The home infusion therapy market is segregated into product, application, and region.

Based on product, the industry is classified into infusion pumps, needless connectors, intravenous sets, and IV cannulas. Home infusion therapy market share from the needless connectors segment is expected to go beyond USD 25 billion by 2032. Needleless connectors are widely used for central, arterial, and peripheral catheters.

Increasing use of needle-free connectors can be attributed to the advantages such as faster and safer access to the infusion line and reduced risk of accidental puncture and infection. These devices also help prevent contamination of patients’ catheters and reduce the risk of device occlusion.

With respect to application, the home infusion therapy market is fragmented into chemotherapy, hydration therapy, specialty pharmaceuticals, anti-infective, hydration therapy, enteral nutrition, parenteral nutrition, and others. The industry share from the specialty pharmaceuticals segment is poised to reach over USD 10.5 billion by 2032.

Specialty drugs are administered via home infusion systems to treat complex and rare diseases through monitored dosage. The rising prevalence of chronic diseases is expected to propel the demand for home infusion devices for the administration of specialty drugs.

From a regional perspective, the Asia Pacific home infusion therapy market is anticipated to exhibit over 12% CAGR by 2032. The presence of a robust geriatric population, increasing cases of cancer, and a growing burden on healthcare will complement regional industry growth. APAC countries such as India and China are ramping up efforts to incorporate skilled healthcare experts by providing training and incentivizing younger doctors.